article thumbnail

U.S. Pharmaceutical company improved quality of overall documentation saving time and filing delays

Impact Pharmaceutical Services

Challenge Syner-G was contracted by a US Pharmaceutical Company to help improve the quality of submission documentation generated during the manufacture of a Drug Substance intended for Phase II trials. Results Syner-G reviewed each documentation and provided suggestions/comments/guidance to the CDMO to bridge the gaps observed.

article thumbnail

STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies. Continue to STAT+ to read the full story…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Discover the leading patient adherence pharmaceutical companies. Pharmaceutical Technology has listed the top patient adherence pharmaceutical companies based on our intel, insights and decades-long expertise in the sector. Patient adherence.

article thumbnail

NICE recommends first licenced treatment for AL amyloidosis

European Pharmaceutical Review

According to the Janssen Pharmaceutical Companies of Johnson & Johnson and NICE, DVCd is recommended for the rare bone marrow disorder, only if daratumumab is stopped after 24 cycles of treatment, or earlier if the condition progresses.

article thumbnail

Pumping the unemployed with weight-loss drugs echoes Victorian attitudes to the poor | Kenan Malik

The Guardian - Pharmaceutical Industry

According to internal documents obtained by the Observer , Novo Nordisk wanted “data from the Department for Work and Pensions” to “ help profile those who are most likely to return to the labour market”. These individuals could then be targeted with Wegovy, the brand name for the company’s weight-loss drug semaglutide.

article thumbnail

QMS market to value nearly $4b by 2030

European Pharmaceutical Review

Some pharmaceutical companies are increasing their R&D spending to increase product numbers. With major pharmaceutical companies implementing these approaches, this is a major contributing factor to rapid growth of this sector. Also noted in the report was the shift towards cloud-based systems.

article thumbnail

Ex-Merck & Co scientist accused of stealing trade secrets could face jail

pharmaphorum

In a document outlining the charges against Shafat Quadri, of North Potomac, Maryland the US Department of Justice (DoJ) referred only to “one of the largest pharmaceutical companies in the world” based in New Jersey.